Jonathan Siddharth × Molly O'Shea

Healthcare AI has crossed O'Shea’s threshold for measurable impact, with biological and chemical models, laboratory robotics and simulations targeting drug development’s high failure rates.After a decade building licenses, networks and care infrastructure, Devoted Health tripled in size, halved operating expenses and significantly increased EBITDA, while China’s rising pharmaceutical research share leaves domestic research and regulatory capacity as risks to monitor.

Peter Diamandis × Salim Ismail × Dave Blundin × Alexander Wissner-Gross × Ben Lamm

Colossal is now worth over $10 billion with more than four spin-offs, while AI connects fragmented research and addresses 40–60% replication failure through standardized language.That data infrastructure may matter more than the model itself as comparative genomics spans thousands of genomes.Colossal has surpassed 300 edits at over 90% efficiency and is testing 1,000, with large-fragment DNA synthesis and a fully extrauterine mammalian birth within 24 months as catalysts amid ethical and regulatory constraints.

Daniel Ek

Spotify passed 700 million active users and 300 million premium subscribers; Daniel Ek became executive chairman January 1 and returned to building.Neko's $499 unit-economic-positive visit combines 53 blood markers, 6,000 images and clinician review in roughly an hour.Over 100,000 scans found serious, previously undiagnosed conditions in roughly 1% of members; population outcomes and budget effects remain unresolved.

Yiwen × Matteo Franceschetti × Alex Zatarain

Eight Sleep以实时响应而非单纯追踪形成差异化，AI可在睡眠期间调节温度、床头高度和声音。专利、自有传感器与专有数据构成护城河，中国是增长最快市场；FDA睡眠呼吸暂停检测与缓解审批是催化剂，但准确率仍未按任务明确。

Peter Diamandis × Martine Rothblatt

United Therapeutics has four thymus shots on goal, including an FDA-approved xenothymus program and newly acquired Thymmune, making thymic replacement Rothblatt’s “most practical pathway” to LEV in the 2030s.Its xeno-kidney trial is mid-flight, facilities are slated for Rochester in August and Houston in October, and xeno-heart moved to Phase 3 after two patients survived 60 days without heart failure, with IVIVA trials starting in 2028.

Jorge Conde × Stéphane Bancel

Moderna and Merck’s personalized mRNA cancer vaccine met its Phase 3 primary endpoint in melanoma and also hit distant metastasis-free survival at the first interim analysis, with patient availability hoped for in 2027.Phase 2 showed 50% five-year recurrence-free survival versus Keytruda alone and 80% disease-free; inside-cell antigen presentation and a Marlborough facility capable of tens of thousands of doses support scale, while pricing and 20% nonresponse remain watchpoints.

Yushan × 英博

Moderna8月19日单日上涨177%，市场重估焦点转向肿瘤疫苗的增长与定价空间。INTerpath-001试验显示，个性化疫苗联合Keytruda的无复发生存达统计学显著；但OS、HR及亚组数据未披露，商业化仍取决于4至6周生产与耗材成本。

Ben Lamm × Molly O'Shea

Colossal’s woolly mice validated mammoth-editing in 30 days, with 100% healthy births and predicted phenotypes.With $635M raised, its screwworm solution could eradicate the problem in six to seven months versus $1.5B in taxpayer spending over eight years, pending permits.Astromec uses evolutionary-genomics AI for drug discovery; another extinct species may arrive within 12 months, but the target remains undisclosed.

Sarah Guo × Max Hodak

Prima won CE marketing approval in Europe in July, with commercial sales expected in coming weeks after trials let patients with macular degeneration complete Sudoku, crosswords, and read books.Science acquired Pixium’s Stanford-originated implant after about two years, calling it “by far the state-of-the-art”; pricing is unset, while future versions could improve color and expand the population from hundreds of thousands to millions.

李翔 × 夏宁

夏宁称，化学合成AI已达到“十年工作经验化学家”水平，五分钟可跑出客户耗时一两个月设计的路线。合成是DMTA循环瓶颈，若提速十到二十倍，新药和新材料研发通量或提高十到二十倍。商业化需白盒解释、验证和约束，并持续用智能调度压低token成本；SaaS与智能体将长期共存。